Somatostatin receptor manipulation

Digestion

Volumn 57, Issue , 1996, Pages 7-10

  Visser Wisselaar, H A ^a   Hofland, L J ^a   Van Uffelen, C J C ^a   Van Koetsveld, P M ^a   Lamberts, S W J ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Down regulation; Glucocorticoid; Octreotide; Oestradiol; Prolactin; Prolactinoma; Receptor; Somatostatin; Tumour

Indexed keywords

ESTRADIOL; ESTROGEN; GLUCOCORTICOID; MESSENGER RNA; OCTREOTIDE; RADIOLIGAND; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; CELL LINE; CONFERENCE PAPER; DOWN REGULATION; FEMALE; HYPOPHYSIS CELL; MESSENGER RNA SYNTHESIS; NONHUMAN; PRIORITY JOURNAL; PROLACTINOMA; PROTEIN EXPRESSION; PROTEIN MODIFICATION; RADIOTHERAPY; RAT; SCINTIGRAPHY; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; FEMALE; HORMONE ANTAGONISTS; HUMANS; PITUITARY NEOPLASMS; PROLACTINOMA; RATS; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN;

EID: 0029984982     PISSN: 00122823     EISSN: 14219867     Source Type: Journal    
DOI: 10.1159/000201383     Document Type: Article

References (32)

1. Rcichlin S: Somatostatin. N Engl J Med 1983: 309:1495-1501.
2. Patel YC, Murthy KK, Escher EE, Banvillc D, Spiess J, Scrikant CB: Mechanism of action of somatostatin: An overview of receptor function and studies of the molecular characterisation and purification of somatostatin receptor proteins. Metabolism 1990;39(suppl 2):63-69.
3. Bruns C, Weckbecker G, Raulf F, Kaupmann K, Schocffter P, Hoyer D, Liibbert H: Molecular pharmacology of somatostatin receptor subtypes. Ann NY Acad Sci 1994:733:138-146.
4. Hoyer D, Liibbert H, Bruns C: Molecular pharmacology of somatostatin receptors. Naunyn Schmiedcberg's Arch Pharmacol 1994:350: 441-453.
5. Reisine T, Bell GI: Molecular biology of somatostatin receptors. Endocr Rev 1995; 16:427- 442.
6. Reisine T, Bell GI: Molecular properties of somatostatin receptors. Neuroscience 1995:67: 777-790.
7. Lamberts SWJ, Krenning EP, Reubi JC: The role of somatostatin and its analogues in the diagnosis and treatment of tumours. Endocr Rev 1991:12:450-482.
8. l2il-Tyr'J-octreotide: The Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993:20:716-731.
9. lnln-DTPA-J-Pheloctrcotide: A case history. Ann NY Acad Sci 1994;733:496-506.
10. l25I-Tyr']octreotide by mouse and human pituitary tumour cells: Increase by unlabclled octreotide. Endocrinology 1995: 136:3698-3706.
11. Srikant B, Heisler S: Relationship between receptor binding and biopotency of somalosta-tin-14 and somatostatin-28 in mouse pituitary tumour cells. Endocrinology 1985:117:271 - 278.
12. Mahy N, Woolkalis M, Manning D, Reisine T: Characteristics of somatostatin desensitization in the pituitary tumour cell line AtT-20. J Pharmacol Exp Ther 1988;247:390-396.
13. Lamberts SWJ, Reubi JC, Uittcrlinden P, Zui-dcrwijk J, van den Werff P, van Hal P: Studies on the mechanism of action of the inhibitory effect of the somatostatin analogue SMS 201-995 on the growth of the prolactin/adrcno-cor-ticotropin secreting pituitary tumour 7315a. Endocrinology 1986; 118:2188-2194.
14. Koper JW, Hofland LJ, van Koctswcld PM, den Holder F, Lamberts SWJ: Dcsensitization and resensitization of rat pituitary tumour cells tn long-term culture to the effects of the somatostatin analogue SMS 201-995 on cell growth and prolactin secretion. Cancer Res 1990:50: 6238-6242.
15. Lamberts SWJ: The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogues in the treatment of human pituitary' tumours. Endocr Rev 1988;9:417-436.
16. Presky DH, Sehonbrunn A: Somatostatin pre-treatment increases the number of somatostatin receptors in GH4C1 pituitary cells and does not reduce cellular responsiveness to somatostatin. J Biol Client 1988:263:714-721.
17. Bruno JF, Xu Y, Bereiowitz M: Somatostatin regulates somatostatin receptor subtype mRNA expression in GHj cells. Biochcm Bio-phys Res Commun 1994;202:1738-1743.
18. Sehonbrunn A: Glucocorticoids down-regulate somatostatin receptors 011 pituitary cells in culture. Endocrinology 1982:110:1147-1154.
19. Visser-Wisselaar HA, van Llffelen CJC, Lich-tenauer-Kaligis EGR, van Koelsveld PM, Waaijers AM, Mooy DM, Lamberts SWJ, Hofiand LJ: Somatostatin receptor subtype expression on 7315b prolactin secreting rat pituitary tumour cells is regulated by 17-p-estradiol. submitted.
20. Visser-Wisselaar HA, van Koetsveld PM, van Uffelen CJC, Uitlerlinden P, Mooy DM, Lamberts SWJ, Hofland LJ: The transplantable 7315b rat pituitary tumour down-regulated its own SSTR subtype expression via its host in an estradiol-dependent manner, submitted.
21. Kimura N, Hayafuji C, Konagaya H, Takahashi K: 17-Estradiol induces somatostatin (SRIF) inhibition of prolactin release and regulates SRIF receptors in rat anterior pituitary cells. Endocrinology 1986; 119:1028-1036.
22. Kimura N, Hayafuji C, Kimura N: Characterization of 17-p-estradiol-dependent and -independent somatostatin receptor subtypes in rat anterior pituitary. J Biol Chem 1989:264: 7033-7040.
23. Sehonbrunn A, Tashjian AH: Modulation of somatostatin receptors by thyrotropin-releasing hormone in a clonal pituitary cell strain. J Biol Chem 1980;255:190-198.
24. Sussman KE, Mehler PS, Leitner JW, Draznin B: Role of the secretion vesicle in the transport of receptors: Modulation of somatostatin binding to pancreatic islets. Endocrinology 1982: 111:316-323.
25. Draznin B, Leitner JW, Sussman KE: A unique control mechanism in the regulation of insulin secretion: Secrctagogue-induced somatostatin receptor recruitment. J Clin Invest 1985:75: 1510-1516.
26. Viqueric N, Estevc JP, Susini C, Logsdon CD, Vaysse N, Ribet A: Dcxamethasone effects on somatostatin receptors in pancreatic acinar AR4-2J cells. Biochcm Biophys Res Commun 1987;147:942-948.
27. Vidal C, Rauly I, Zeggari M, Delesque N, Eslcvc JP, Saint-Laurent N, Vaysse N, Susini C: Up-regulation of somatostatin receptors by epidermal growth factor and gastrin in pancreatic cancer cells. Mol Pharmacol 1994,45: 97-104.
28. Lamberts SWJ, van Koetsveld PM, Verleun T: Prolactin release-inhibitory effects of progesterone megcstrol acetate, and nnlepristone (RU 38486) by cultured rat pituitary tumour cells. Cancer Res 1987:47:3667-3677
29. Hofland L.I, van Koetsveld PM, Wouters N, Waayers M, Reubi JC, Lamberts SWJ: Dissociation of antiproliferative and antihorntonal effects of the somatostatin analogue octreotide 011 7315b pituitary tumor cells. Endocrinology 1992:131:571-577.
30. Lamberts SWJ, Zweens M, Klijn JGM, van Vroonhoven CCJ, Stefanko SZ, Del Pozo E: The sensitivity of growth hormone and prolactin secretion to the somatostatin analogue SMS 201-995 in patients with prolactinomas and acromegaly. Clin Endocrinol 1986:25:201- 212.
31. Reubi JC, Heitz PU, Landolt AM: Visualization of somatostatin receptors and correlation with immunorcactive growth hormone and prolactin in human pituitary adenomas: Evidence for different tumour subclasses. J Clin Endocrinol Metab 1987,65:65-73.
32. Lamberts SWJ, Hofland LJ, de Herder WW, Kwekkeboom DJ, Reubi JC, Krenning EP: Octreotide and related somatostatin analogues in the diagnosis and treatment of pituitary disease and somatostatin receptor scintigraphy. Front Ncuroendocrinol 1993; 14:27-55.